Luminate Medical
Developed a novel device to prevent hair loss during chemotherapy.
Employees
Enterprise value
$75m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
* | $2.5m Valuation: $75.0m | Series A | |
| Total Funding | 000k | ||
| EUR | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 299 % | 17 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (63 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (65 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Notes (0)
More about Luminate Medical
EditMade with AI
Developer of a novel device designed to prevent hair loss during chemotherapy. The company provides a unique portable, comfortable, and wearable solution that allows patients to maintain their confidence and dignity during treatment, enabling patients to prevent and control the side effects of cancer treatment.
Keywords: Healthcare Devices, Services, Supplies, Cancer Care, Cancer Treatment, Hair Loss Treatment, Medical Device, Medical Technology, Therapeutic Approaches.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.